Page last updated: 2024-11-02

oxymetazoline and Craniofacial Abnormalities

oxymetazoline has been researched along with Craniofacial Abnormalities in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Menezes, GA1
Araujo JĂșnior, E1
Lopes, J1
Belmonte, S1
Tonni, G1
Werner, H1

Other Studies

1 other study available for oxymetazoline and Craniofacial Abnormalities

ArticleYear
Prenatal diagnosis and physical model reconstruction of agnathia-otocephaly with limb deformities (absent ulna, fibula and digits) following maternal exposure to oxymetazoline in the first trimester.
    The journal of obstetrics and gynaecology research, 2016, Volume: 42, Issue:8

    Topics: Adult; Branchial Region; Craniofacial Abnormalities; Female; Fibula; Fingers; Humans; Image Interpre

2016